ESPEN guideline on clinical nutrition in liver disease
- PMID: 30712783
- PMCID: PMC6686849
- DOI: 10.1016/j.clnu.2018.12.022
ESPEN guideline on clinical nutrition in liver disease
Abstract
This update of evidence-based guidelines (GL) aims to translate current evidence and expert opinion into recommendations for multidisciplinary teams responsible for the optimal nutritional and metabolic management of adult patients with liver disease. The GL was commissioned and financially supported by ESPEN. Members of the guideline group were selected by ESPEN. We searched for meta-analyses, systematic reviews and single clinical trials based on clinical questions according to the PICO format. The evidence was evaluated and used to develop clinical recommendations implementing the SIGN method. A total of 85 recommendations were made for the nutritional and metabolic management of patients with acute liver failure, severe alcoholic steatohepatitis, non-alcoholic fatty liver disease, liver cirrhosis, liver surgery and transplantation as well as nutrition associated liver injury distinct from fatty liver disease. The recommendations are preceded by statements covering current knowledge of the underlying pathophysiology and pathobiochemistry as well as pertinent methods for the assessment of nutritional status and body composition.
Keywords: Acute liver failure; Alcoholic steatohepatitis; Cirrhosis; Fatty liver disease; Sarcopenia; Transplantation.
Copyright © 2019 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Conflict of interest
The expert members of the working group were accredited by the ESPEN Guidelines Group, the ESPEN Education and Clinical Practice Committee, and the ESPEN executive. All expert members have declared their individual conflicts of interest according to the rules of the International Committee of Medical Journal Editors (ICMJE). If potential conflicts were indicated, they were reviewed by the ESPEN guideline officers and, in cases of doubts, by the ESPEN executive. None of the expert panel had to be excluded from the working group or from co-authorship because of serious conflicts. The conflict of interest forms are stored at the ESPEN guideline office and can be reviewed by ESPEN members with legitimate interest upon request to the ESPEN executive.
Comment in
-
Should we introduce a feeding tube before assessing the risk of variceal bleeding?Clin Nutr. 2020 Apr;39(4):1304. doi: 10.1016/j.clnu.2020.02.005. Epub 2020 Feb 14. Clin Nutr. 2020. PMID: 32107058 No abstract available.
References
-
- Child CGTJ. Surgery and portal hypertension. In: CG C, editor. The Liver and Portal Hypertension Philadelphia: Saunders; 1964. p. 50–1.
-
- Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Müller M, et al. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997;16(2):43–55. - PubMed
-
- Plauth M, Cabre E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J, et al. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 2006;25(2):285–94. - PubMed
-
- Plauth M, Cabre E, Campillo B, Kondrup J, Marchesini G, Schütz T, et al. ESPEN guidelines on parenteral nutrition: hepatology. Clin Nutr 2009;28(4):436–44. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
